|
|
| Thérapies > Etude de marché sectorielle |
| Disease and Therapy Review: Epilepsy |
|
|
|
|
€ 720,00 |
Editeur
: |
Timely Data Resources, Inc. |
Langue
: |
Anglais |
Date de publication : |
Septembre 2006 |
Taille du document : |
8 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Stakeholder Insight: Prostate Cancer - A Prostrate Market Waiting for Innovations
312 pages | Octobre 2005 |
IntroductionThe prostate cancer market is reaching maturity, and major players' sales have been eroded by the launch of various LHRH agonist depot formulations.
Safety concerns with AstraZeneca's C |
12 920,00 €
|
| |
| |
Nutraceuticals - Targeting Consumers Aged 14 –34
146 pages | Septembre 2000 |
The 14-34 age group represents approximately 30% of the total population across the 8 countries covered in the report, and as such are a key target audience.
This group is particularly critic |
955,00 €
|
| |
| |
Pipeline Insight: ADHD - Shire Driving Diversity in ADHD
205 pages | Juin 2005 |
IntroductionThe current ADHD market has long been saturated with traditional methylphenidate and amphetamine based drugs, with the only innovations being the development of extended release versions.< |
9 120,00 €
|
| |
| |
MarketWatch: CNS
25 pages | Février 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
MarketWatch: Cancer
33 pages | Mars 2005 |
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the cancer therapeutic area.
MarketWatch features all the |
160,00 €
|
| |
| |
The Cancer Market Outlook to 2010
192 pages | Novembre 2005 |
The cancer market has undergone a high degree of innovation led change over the previous five years, which has created strong opportunities for a range of established and emerging biotechnology and ph |
2 443,75 €
|
| |
| |
MarketWatch: CNS
29 pages | Octobre 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
170,00 €
|
| |
| |
MarketWatch: CNS
28 pages | Juin 2005 |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
The Latin American Cancer Market Outlook to 2010
173 pages | Novembre 2005 |
The patient pool for cancer therapies is rising at a higher rate than the growth rate in population across the ten Latin American pharmaceutical markets, a trend primarily driven by the rising life ex |
2 443,75 €
|
| |
| |
The Cancer Outlook 2000
128 pages | Septembre 2000 |
Driven by the cytotoxic, adjunct and innovative drug classes, the cancer market grew by 16% in 1999 to a global value of almost $19bn, and is now poised on the verge of a period of significant exp |
955,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Disease and Therapy Review: Epilepsy |
|
|
The Epilepsy Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatments. Dosing information is provided for a large number of products, including Neurontin, Keppra, Lyrica, Depakote, and Klonopin. General information is provided about sales performance for major products.
Additional Information
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
|
|
I. Overview
II. Incidence and Prevalence
Incidence Table: (US, UK, Japan, Worldwide)
Prevalence Table: (US, UK, Germany, Japan, China, India, Worldwide)
III. Diagnosis
IV. Treatment
V. Dosing
Grand mal or partial seizures
Petit mal seizures
Myoclonic seizures
VI. Market Size
VII. COMMENTS
VIII. References/Resources
|
|
|
PPLSEN
|
|
|
|
|
